WHO ICTRP trial
Effects of metformin on hepatic lipid metabolism
EUCTR2012-000808-16-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-000808-16-DK |
|---|---|
| Public title | Effects of metformin on hepatic lipid metabolism |
| Scientific title | Effects of metformin on hepatic free fatty acid metabolism in type 2 diabetes asssessed by positron emission tomography |
| Primary sponsor | Aarhus University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Type 2 diabetes and dyslipidemia MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Body processes [G]… |
| Interventions | Trade Name: Metformin "Teva" Product Name: Metformin "Teva" Pharmaceutical Form: Coated tablet INN or Proposed INN: METFORMIN CAS Number: 657-24-9 Concentration unit: mg milligram(s) Concentration type: range Concentration number: 1000-2000… |
| Registration date | Mar 22, 2013 |
| Secondary IDs | C11palmitatmetformin |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: